GL1X · GenesisL1 explorer

Research workbench

2-[2-(4-phenyl-1H-imidazol-2-YL)ETHYL]QUINOXALINE (sunovion compound 14) co-crystallized with PDE10A

Analyse 2-[2-(4-phenyl-1H-imidazol-2-YL)ETHYL]QUINOXALINE (sunovion compound 14)… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4YQH
Type
protein
Length
642 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10A
EC
3.1.4.17, 3.1.4.35
UniProt
Q9Y233
Ligands
4F7, ZN, MG
Pockets
6 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 73% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BCamp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17, 3.1.4.35)protein32173% helix, 0% strandQ9Y233

Ligands and binding sites

  • 4F7 · 2-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]quinoxaline · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16360.730.8066MG, 4F7
24190.720.8352MG, 4F7
36740.690.7761empty
4980.380.7517empty
5780.360.7713empty

Interfaces

1 interface between chains.

  • A–B · 712 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 4YQH · 2-[2-(4-Phenyl-1H-imidazol-2-yl)ethyl]quinoxaline (Sunovion Compound 14) co-crystallized… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.